Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. ABC.L Share Price
  4. ABC.L Share News
  5. BROKER RATINGS SUMMARY: HSBC Raises Berkeley And McCarthy & Stone

Pin to quick picksABC.L Share News (ABC)

ABC.L Information
  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: HSBC Raises Berkeley And McCarthy & Stone

Mon, 09th Sep 2019 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

HSBC RAISES BERKELEY GROUP TO 'BUY' ('HOLD') - PRICE TARGET 4540 (4130) PENCE

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 4800 (4700) PENCE - 'BUY'

----------

HSBC CUTS TAYLOR WIMPEY PRICE TARGET TO 210 (230) PENCE - 'BUY'

----------

HSBC CUTS PERSIMMON PRICE TARGET TO 2750 (2960) PENCE - 'BUY'

----------

HSBC CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 750 (770) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ST JAMES'S PLACE PRICE TARGET TO 980 (1030) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS LEGAL & GENERAL PRICE TARGET TO 245 (260) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 7800 (7600) PENCE - 'BUY'

----------

BERENBERG CUTS CENTRICA PRICE TARGET TO 80 (140) PENCE - 'HOLD'

----------

BERENBERG RAISES LONDON STOCK EXCHANGE PRICE TARGET TO 8115 (6340) PENCE - 'BUY'

----------

FTSE 250

----------

BERENBERG CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY') - TARGET 572 (475) PENCE

----------

UBS CUTS ASHMORE GROUP PRICE TARGET TO 480 (505) PENCE - 'NEUTRAL'

----------

DAVY CUTS WIZZ AIR TO 'NEUTRAL' ('OUTPERFORM')

----------

RBC CUTS DUNELM GROUP PRICE TARGET TO 850 (900) PENCE - 'UNDERPERFORM'

----------

BARCLAYS CUTS ASHMORE GROUP PRICE TARGET TO 520 (540) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES ULTRA ELECTRONICS TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TARGET 2000 (1120) PENCE

----------

HSBC CUTS REDROW PRICE TARGET TO 770 (790) PENCE - 'BUY'

----------

HSBC CUTS BOVIS HOMES PRICE TARGET TO 1300 (1350) PENCE - 'BUY'

----------

HSBC CUTS ASTON MARTIN LAGONDA PRICE TARGET TO 533 (1032) PENCE - 'HOLD'

----------

HSBC RAISES MCCARTHY & STONE TO 'BUY' ('HOLD') - TARGET 160 (150) PENCE

----------

HSBC RAISES CREST NICHOLSON PRICE TARGET TO 540 (510) PENCE - 'BUY'

----------

HSBC RAISES BELLWAY PRICE TARGET TO 4290 (4250) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES MITCHELLS & BUTLERS TO 'OVERWEIGHT' ('EQUAL-WEIGHT')

----------

JEFFERIES RAISES PLAYTECH PRICE TARGET TO 620 (570) PENCE - 'BUY'

----------

JEFFERIES RAISES INTERMEDIATE CAPITAL PRICE TARGET TO 1600 (1570) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

RBC INITIATES SPIRE HEALTHCARE WITH 'OUTPERFORM' - TARGET 149 PENCE

----------

RBC CUTS ABCAM PRICE TARGET TO 1300 (1410) PENCE - 'SECTOR PERFORM'

----------

More News
31 Jul 2018 15:42

Berenberg changes mind on Abcam, reinstating 'buy' rating

(Sharecast News) - Analysts at Berenberg on Tuesday upgraded their rating for shares of Abcam from 'Hold' to 'Buy' after having downgraded shares of the antibodies supplier just three months ago.

Read more
31 Jul 2018 13:26

Tuesday broker round-up

(Sharecast News) - Abcam: Berenberg upgrades to buy with a target price of 1,640p.

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
9 May 2018 16:16

UPDATE: Horizon Discovery Outlook Strong In Face Of Abcam Pull-Out

LONDON (Alliance News) - Horizon Discovery Group PLC on Wednesday noted Abcam PLC's statement earlier in the day it will not be making an offer for Horizon.The gene modulation company a

Read more
9 May 2018 12:33

Abcam Decides Not To Make An Offer For Horizon Discovery Group

LONDON (Alliance News) - Abcam PLC on Wednesday said it has ended plans to make an offer for Horizon Discovery Group PLC following the latter's release of its annual results and a management a

Read more
2 May 2018 18:25

Horizon Discovery Confirms Rejected "Unsolicited" Abcam Proposal

LONDON (Alliance News) - Genomics firm Horizon Discovery Group PLC on Wednesday confirmed it had rejected an unsolicited and "highly conditional" proposal from Abcam PLC.The life

Read more
2 May 2018 16:41

Horizon Discovery Rejects GBP270.0 Million Proposal From Abcam

LONDON (Alliance News) - Abcam PLC on Wednesday said gene editing company Horizon Discovery Group PLC has rejected its acquisition proposal.The life science e-commerce company said it a for

Read more
15 Mar 2018 09:53

BROKER RATINGS SUMMARY: Barclays Reviews Banks, Goldman Property Firms

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE WITH

Read more
7 Mar 2018 15:23

FDA head Gottlieb criticizes industry for "Kabuki drug-pricing"

WASHINGTON, March 7 (Reuters) - U.S. Food and Drug Administrator Scott Gottlieb on Wednesday criticized drugmakers, pharmacy benefit managers and health a

Read more
11 Jan 2017 09:36

BROKER RATINGS SUMMARY: Morgan Stanley Upgrades BT To Overweight

Read more
10 Jan 2017 10:30

Abcam's revenue to be ahead of expectations

(ShareCast News) - Cambridge-based life science company Abcam said it anticipates revenue will continue to grow in the second half of the year, ahead of expectations. The AIM-listed company company expects revenue to grow 10% on a constant currency basis and 30% on a reported basis as it is on track

Read more
24 Oct 2016 10:28

Abcam commits to massive new Cambridge headquarters

(ShareCast News) - Life science research tools supplier Abcam announced on Monday that it has committed to the lease of a new facility for its global headquarters at the Biomedical Campus in Cambridge, subject to the grant of full planning approval. The AIM-traded firm said the purpose-built facilit

Read more
28 Sep 2016 11:29

DIRECTOR DEALINGS: Abcam COO Donates 62,000 Shares to Charity

Read more
12 Sep 2016 10:40

Abcam earnings dip slightly in year of investment

(ShareCast News) - Life science research tool supplier Abcam announced its preliminary results for the year to 30 June on Monday, with catalogue revenue increasing by 17.4% on a reported basis to £159.0m. The AIM-traded firm said at constant exchange rates the increase was 14.4%. Total revenue incr

Read more
2 Sep 2016 10:21

Abcam to place shares on AIM to pay vendors following acquisition

(ShareCast News) - Life science company Abcam is to pay the first performance-based payment of $5.2m for its acquisition of AmioMx through a share placing on AIM, the London Stock Exchange's junior market. The Cambridge-based company bought AmioMx in November 2015 which included an agreement to make

Read more
789101112131415

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.